Tardive dyskinesia and other movement disorders secondary to aripiprazole
- 3 September 2010
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 26 (1), 147-152
- https://doi.org/10.1002/mds.23402
Abstract
The objective of this report is to draw attention to tardive dyskinesia (TD) caused by aripiprazole, a third generation antipsychotic. TD has been traditionally attributed to typical (first-generation) antipsychotics, but other dopamine receptor blocking drugs and atypical (second- and third-generation) neuroleptics are emerging as an important cause of TD. We reviewed the medical records of patients with TD seen at the Baylor College of Medicine Movement Disorders Clinic between 2002 and 2010 to identify patients with TD associated with aripiprazole. Among 236 patients with TD seen over the specified period, 8 (3.4%) were found to have aripiprazole-associated TD. In 5 patients, TD occurred after exclusive exposure to aripiprazole. The mean age at onset was 55.8 ± 14.8 years with a female predominance. The average duration of treatment with aripiprazole was 18.4 ± 26.4 months. Oro-bucco-lingual stereotypy was seen in all patients. In most patients, TD did not spontaneously improve after stopping aripiprazole. Of the 5 patients treated with tetrabenazine, 4 improved during follow-up. Although aripiprazole, a third generation antipsychotic, has been promoted to have a low risk of TD, the drug accounts for about 3.5% of patients with TD evaluated in a movement disorders clinic. This largest reported series draws attention to the growing incidence of TD and other drug-induced movement disorders associated with “atypical antipsychotics.” © 2010 Movement Disorder SocietyKeywords
This publication has 58 references indexed in Scilit:
- Incidence of Tardive Dyskinesia With Atypical Versus Conventional Antipsychotic MedicationsThe Journal of Clinical Psychiatry, 2010
- Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive DisorderThe Primary Care Companion For CNS Disorders, 2009
- MOVEMENT DISORDERS ASSOCIATED WITH ARIPIPRAZOLE USE: A CASE SERIESInternational Journal of Neuroscience, 2009
- Use of aripiprazole in tardive dyskinesia: An open label study of six casesThe World Journal of Biological Psychiatry, 2009
- A case of aripiprazole and tardive dyskinesiaJournal of Psychopharmacology, 2008
- Metoclopramide, an Increasingly Recognized Cause of Tardive DyskinesiaThe Journal of Clinical Pharmacology, 2008
- Aripiprazole-Induced Tardive Dyskinesia: The Role of TamoxifenAmerican Journal of Psychiatry, 2007
- Aripiprazole: pharmacology and evidence in bipolar disorderExpert Opinion on Pharmacotherapy, 2007
- Nontricyclic AntidepressantsJournal of Clinical Psychopharmacology, 2006
- Extrapyramidal Symptoms with Atypical AntipsychoticsDrug Safety, 2005